275 related articles for article (PubMed ID: 22652136)
1. A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.
Reddy A; Hui D; Bruera E
J Pain Symptom Manage; 2012 Jul; 44(1):124-30. PubMed ID: 22652136
[TBL] [Abstract][Full Text] [Related]
2. A palliative care intervention for pain refractory to a percutaneous cordotomy.
de la Cruz M; Reddy A; Bruera E
Palliat Support Care; 2015 Apr; 13(2):395-8. PubMed ID: 24717241
[TBL] [Abstract][Full Text] [Related]
3. Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?
Shinde S; Gordon P; Sharma P; Gross J; Davis MP
Support Care Cancer; 2015 Mar; 23(3):695-703. PubMed ID: 25168780
[TBL] [Abstract][Full Text] [Related]
4. Effects of palliative intrathecal analgesia on patients with refractory cancer bone pain.
Haraga I; Kosugi T; Sadashima E; Yumiba T; Kubo M; Ishikawa-Konishi A; Akiyoshi K
J Anesth; 2024 Jun; 38(3):405-411. PubMed ID: 38565691
[TBL] [Abstract][Full Text] [Related]
5. Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.
Ju Y; Tian D; Tan Y; Fu Z
Medicine (Baltimore); 2018 Jan; 97(4):e9714. PubMed ID: 29369202
[TBL] [Abstract][Full Text] [Related]
6. Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance?
Sallerin-Caute B; Lazorthes Y; Deguine O; Francés B; Verdié JC; Charlet JP; Bastide R
Neurosurgery; 1998 Jan; 42(1):44-9; discussion 49-50. PubMed ID: 9442502
[TBL] [Abstract][Full Text] [Related]
7. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
[TBL] [Abstract][Full Text] [Related]
8. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.
Rauck RL; Cherry D; Boyer MF; Kosek P; Dunn J; Alo K
J Pain; 2003 Oct; 4(8):441-7. PubMed ID: 14622664
[TBL] [Abstract][Full Text] [Related]
9. The need for a multidisciplinary approach to pain management in advanced cancer: A clinical case.
Didwaniya N; Tanco K; de la Cruz M; Bruera E
Palliat Support Care; 2015 Apr; 13(2):389-94. PubMed ID: 25907373
[TBL] [Abstract][Full Text] [Related]
10. The control of severe cancer pain by continuous intrathecal infusion and patient controlled intrathecal analgesia with morphine, bupivacaine and clonidine.
Tumber PS; Fitzgibbon DR
Pain; 1998 Dec; 78(3):217-220. PubMed ID: 9870575
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal infusions for intractable cancer pain: a qualitative study of the impact on a case series of patients and caregivers.
Hawley P; Beddard-Huber E; Grose C; McDonald W; Lobb D; Malysh L
Pain Res Manag; 2009; 14(5):371-9. PubMed ID: 19862372
[TBL] [Abstract][Full Text] [Related]
12. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
Mitchell A; McGhie J; Owen M; McGinn G
Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
[TBL] [Abstract][Full Text] [Related]
13. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
[TBL] [Abstract][Full Text] [Related]
15. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
16. Interest of repetitive transcranial magnetic stimulation of the motor cortex in the management of refractory cancer pain in palliative care: Two case reports.
Nizard J; Levesque A; Denis N; de Chauvigny E; Lepeintre A; Raoul S; Labat JJ; Bulteau S; Maillard B; Buffenoir K; Potel G; Lefaucheur JP; Nguyen JP
Palliat Med; 2015 Jun; 29(6):564-8. PubMed ID: 25739966
[TBL] [Abstract][Full Text] [Related]
17. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
18. More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain.
Mitchell A; Somerville L; Williams N; McGhie J; McConnachie A; McGinn G; Lee J
Palliat Med; 2023 Oct; 37(9):1461-1466. PubMed ID: 37632373
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous morphine is superior to intrathecal morphine for pain control in a patient with hypernephroma.
Devulder JE
J Clin Anesth; 1998 Mar; 10(2):163-5. PubMed ID: 9524905
[TBL] [Abstract][Full Text] [Related]
20. Exploration of cancer pain treatment by morphine infusion through an embedded device.
Yang Y; Li Y; Huang XE; Lu YY; Wu XY
Asian Pac J Cancer Prev; 2011; 12(11):3151-2. PubMed ID: 22394006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
